Srikanta Basu

Publications

377

Citations

H-Index

2002

Active since

Affiliations

Advanced Centre for Treatment, Research and Education in Cancer(Current)

Tata Memorial Hospital

National Cancer Institute

Tata Institute of Fundamental Research

Homi Bhabha National Institute

Srikanta Basu is an author at Advanced Centre for Treatment, Research and Education in Cancer specializing in medicine, cell biology, and tumor microenvironment.

ORCID

Top concepts

MedicineCell BiologyTumor MicroenvironmentPathologyImmunologyTumor BiologyCancer BiologyCell SignalingCell ProliferationSignal Transduction

Publications per year

2002–2023

Publications

Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer

Nazia Chaudhary, Bhagya Shree Choudhary, Sanket Shah et al. · International Journal of Cancer · 2021 · 180 citations

MMP7 Is Required to Mediate Cell Invasion and Tumor Formation upon Plakophilin3 Loss

Srikanta Basu, Rahul Thorat, Sorab N. Dalal · PLoS ONE · 2015 · 46 citations · Full text

Gene Signature, Immunology, Pathology +18

14-3-3γ Prevents Centrosome Amplification and Neoplastic Progression

Amitabha Mukhopadhyay, Lalit Sehgal, Arunabha Bose et al. · Scientific Reports · 2016 · 34 citations · Full text

Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4

Qiong Meng, Chen Chen, Na Yang et al. · Proceedings of the National Academy of Sciences · 2023 · 33 citations · Full text

Apoptosis, Immunology, Molecular Biology +19

Plakophilin3 loss leads to an increase in lipocalin2 expression, which is required for tumour formation

Srikanta Basu, Nazia Chaudhary, Sanket Shah et al. · Experimental Cell Research · 2018 · 30 citations

Tumour Formation, Signal Transduction, Signaling Pathway +11

Rows per page

1–5 of 8